[ Price : $8.95]
As incoming House Government Reform chairman Henry Waxman takes note, Sen. Chuck Grassley lambastes FDA secrecy and alleged intimi...[ Price : $8.95]
FDA approves a Millennium Pharmaceuticals supplemental NDA for Velcades use in treating relapsed mantle cell lymphoma.[ Price : $8.95]
Federal Register Final rule: FDA approves an Agri Laboratories ANADA that provides for oral use of lyncomycin and spectinomycin to...[ Price : $8.95]
The HHS Inspector General says FDA should do more to implement 2003 corrective actions called for by the commissioner to improve r...[ Price : $8.95]
A Harris Interactive/Wall Street Journal Online poll finds that 62% of adults would support prohibiting off-label prescription dru...[ Price : $8.95]
FDAs Clinical Chemistry and Clinical Toxicology Devices Panel says lipid subfraction assays may have some value in assessing patie...[ Price : $8.95]
FDA sets a user fee action date of 4/26/07 for Sanofi-Aventis NDA resubmission on weight-loss drug Acomplia.[ Price : $8.95]
FDA and Baxter warn healthcare professionals about the possibility of delayed onset of heparin-induced thrombocytopenia.